4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
SSY Group Limited (2005) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 5,400 employees. Its market capitalization is roughly HK$8 billion. In the fiscal year ended 2025-12-31, 2005 reported HK$4.2B in revenue and HK$471M in net income.
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally.
Interactive charts & full statements → Open the 2005 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | HK$4.2B | HK$5.8B | HK$6.5B | HK$6.4B | — |
| Gross Profit | HK$1.7B | HK$2.9B | HK$3.6B | HK$3.6B | — |
| Operating Income (EBIT) | HK$584M | HK$1.3B | HK$1.6B | HK$1.4B | — |
| Net Income | HK$471M | HK$1.1B | HK$1.3B | HK$1.1B | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (HK$427M) | (HK$534M) | (HK$446M) | (HK$388M) | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$12.8B | HK$12.6B | HK$12.0B | HK$11.0B | — |
| Total Liabilities | HK$5.2B | HK$5.1B | HK$4.7B | HK$4.4B | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2005 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms